Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

May 02, 2024 08:00 ET
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024
Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver nine presentations offering insights into its adeno-associated virus (AAV) research and...
May 02, 2024 08:00 ET
CDT Environmental Technology Investment Holdings Limited Receives Three New Utility Model Patent Allowances from the China National Intellectual Property Administration (CNIPA)
CDT Environmental Technology Investment Holdings Limited (NASDAQ: CDTG) (“CDT”), a leading provider of waste treatment systems and services throughout China, announces the granting of three patents from the China National Intellectual Property...
May 02, 2024 08:00 ET
Dremio and VAST Data Build the First Zero Trust Data Lakehouse Platform - Sets a New Standard for Data Security and Accessibility
Dremio, the unified lakehouse platform for self-service analytics and AI, and VAST Data, the AI data platform company, today announced a strategic partnership that signifies a pivotal step towards building the first Zero Trust lakehouse platform...
May 02, 2024 08:00 ET
Fengate adds six seniors housing facilities to its U.S. healthcare and seniors housing portfolio
Fengate Asset Management (Fengate) is pleased to announce the financial close of six seniors housing facilities as part of a new joint venture with leading United States healthcare and seniors housing partners, Boldt and New Perspective. The...
May 02, 2024 08:00 ET
Kawasaki Robotics Shares First Look of New Collaborative Robots, Features New Partnerships and Applications for Industrial Robots at AUTOMATE 2024
WIXOM, Michigan, May 2, 2024– Kawasaki Robotics, a manufacturer of high-quality, intuitive and productive industrial robots for every industry, will offer a first look at its new family of collaborative robots (cobots) next week at Automate 2024 in...
May 02, 2024 08:00 ET
Official Announcement: $DEDE, the New Dino-Themed Meme Coin on Solana Blockchain
Introduction of $DEDE on the Solana Blockchain $DEDE is a new cryptocurrency that features a distinctive dinosaur-themed design. It has recently been launched on the Solana blockchain, introducing a unique and playful element to the diverse world...
May 02, 2024 08:00 ET
Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that Patrick Cushing, Ph.D., has been promoted to Vice President Operations of Rentschler Biopharma, Inc.,...
May 02, 2024 08:00 ET
SPAR Group Announces Closing of South Africa Joint Venture Sale
SPAR Group, Inc. (NASDAQ: SGRP) (“SPAR,” “SPAR Group,” or the “Company”), a provider of merchandising, marketing, and distribution services, announces the closing of the sale of its majority share in South Africa’s Meridian Group to the minority...
May 02, 2024 08:00 ET
VoIP-Pal Receives a Favorable Ruling in the Northern District of Texas
VoIP-Pal.com Inc. (“VoIP-Pal”, “Company”) (OTCQB: VPLM) is pleased to announce that the Northern District of Texas has denied Huawei’s motion for judgment on the pleadings in VoIP-Pal.com Inc v. Huawei Technologies Co LTD, 3:23-cv-00151-X (N.D....
May 02, 2024 08:00 ET
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (“WELL”), a digital health company focused on tech-enabling healthcare providers, and its investee company, HEALWELL AI (TSX: AIDX) (“HEALWELL”), are pleased to announce the launch of the...
May 02, 2024 07:59 ET
CompTIA introduces new Data Advisory Council to help businesses foster data-driven culture
CompTIA, the nonprofit association for the information technology (IT) industry, has expanded its role in fostering a data-driven culture with the formation of a new CompTIA Community Data Advisory Council. The council, comprised of six industry...
May 02, 2024 07:35 ET
CoreCard Corporation Reports First Quarter 2024 Results
CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, announced today its financial results for the...
May 02, 2024 07:31 ET
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a biopharmaceutical company advancing medicines for solid tumors, today announced that the U.S. Food and Drug Administration (“FDA”) has cleared its Investigational New Drug...
May 02, 2024 07:30 ET
Parker Reports Fiscal 2024 Third Quarter Results
Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the fiscal 2024 third quarter ended March 31, 2024. Sales were $5.07 billion compared with $5.06 billion in the third quarter...
May 02, 2024 07:30 ET
Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2024 financial results on Thursday, May 9, 2024 and will provide a business update. Altimmune management will host a...
May 02, 2024 07:30 ET
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s...
May 02, 2024 07:30 ET
AppTech Payments Corp. to Present at Sidoti Virtual Investor Conference May 8-9
AppTech Payments Corp. (NASDAQ: APCX), a pioneering Fintech company powering frictionless commerce, announced Luke D’Angelo, Chairman & CEO, will present and host one-on-one meetings with investors at the Sidoti May Virtual Investor Conference,...
May 02, 2024 07:30 ET
Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update
Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV)...
May 02, 2024 07:30 ET
Biogen Reports Progress on Corporate Responsibility Priorities
Biogen Inc. (Nasdaq: BIIB) today announced publication of its 2023 Corporate Responsibility Report detailing progress on the company’s commitment to making responsible business decisions in the best interests of all its stakeholders. “As we...
May 02, 2024 07:30 ET
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today reported its financial results for the first quarter ended March 31, 2024, and provided an...